Log on / register
Feedback | Support | My details

Pre-publication history

An A2A adenosine receptor agonist, ATL313, reduces inflammation and improves survival in murine sepsis models

Christopher C Moore email, Edward N Martin email, Grace H Lee email, Tom Obrig email, Joel Linden email and W Michael Scheld email

BMC Infectious Diseases 2008, 8:141doi:10.1186/1471-2334-8-141

Pre-publication versions of this article and reviewers' reports

Original submission - Version 1Manuscript09 Jun 2008
Reviewer's ReportEdward Sherwood08 Jul 2008
Reviewer's ReportMichail Sitkovsky30 Jul 2008
Reviewer's ReportManping Wu18 Aug 2008
Resubmission - Version 2ManuscriptAuthors' comments28 Aug 2008
Reviewer's ReportManping Wu22 Sep 2008
Reviewer's ReportEdward Sherwood02 Oct 2008
Resubmission - Version 3ManuscriptAuthors' comments20 Oct 2008
Resubmission - Version 4Manuscript20 Oct 2008
Accepted20 Oct 2008
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.